The new rules from the U.S. Treasury and Congress on tax inversions will hurt U.S. corporate profits.
The Allergan/Pfizer deal makes these problems clear.
By Money Morning Member Alert, Money Morning -
The new rules from the U.S. Treasury and Congress on tax inversions will hurt U.S. corporate profits.
The Allergan/Pfizer deal makes these problems clear.
Here's what investors need to know about the new tax rules...
By Money Morning Member Alert, Money Morning -
The new rules from the U.S. Treasury and Congress on tax inversions will hurt U.S. corporate profits.
The Allergan/Pfizer deal makes these problems clear.
Here's what investors need to know about the new tax rules...
By Tara Clarke, Associate Editor, Money Morning • @TaraKateClarke -
Update: Burger King (NYSE: BKW) stock finished down 4.32% Tuesday after the company's morning announcement that it will merge with Ontario-based coffee-and-donut chain Tim Hortons Inc. (USA) (NYSE: THI). THI stock closed up 8.47%.
In contrast, when news of merger talks originated on Monday, and shares in both BKW and THI enjoyed significant gains and ended that trading session up 19.51% and 18.91% respectively.
Here’s why BKW stock took a turn and finished in the red Tuesday – and why it’ll come roaring back…
By David Zeiler, Associate Editor, Money Morning • @DavidGZeiler -
Democrats and Republicans alike are unhappy about the increasing number of so-called tax inversion deals - a merger between a U.S and a foreign company specifically designed to allow the U.S. company to escape America's high corporate tax rate.
Over the past 10 years about 50 U.S. companies have done it, costing the U.S. billions in lost taxes.